Skip to main content

EarlyHealth Group Acquires CYB3R, Gulf’s Fastest-Growing Cybersecurity Firm

Written by Customer Service on . Posted in Mergers And Acquisitions.

DUBAI, United Arab Emirates, Oct. 12, 2025 (GLOBE NEWSWIRE) — EarlyHealth Group, a global pharmaceutical services and life sciences solutions company, has acquired a 50 % equity stake in CYB3R Limited, one of the Gulf’s fastest-growing cybersecurity firms headquartered in Dubai. This strategic diversification and cross-industry investment positions CYB3R with a global footprint whilst expanding its delivery of turnkey solutions to the life sciences industry and government organizations.

CYB3R, owned by tech entrepreneurs Alex Halsall and Jack Tupper, has rapidly gained prominence by securing critical infrastructure and sensitive data in regulated industries across the Middle East and Europe. By embedding CYB3R’s capabilities into EarlyHealth’s global platform, the partnership will scale operations internationally and deliver turnkey solutions that safeguard clinical studies, institutional programs, and government initiatives.

“With a growing portfolio of 1,200 international enterprises and public organizations, our partnership with EarlyHealth marks the next step in scaling CYB3R’s capabilities globally and delivering tailored cybersecurity solutions to our core sectors,” said Alex Halsall, Chief Executive Officer of CYB3R. “Together, we will establish a new benchmark for trusted, compliance-first digital security.”

CYB3R’s leadership team will remain in place post-acquisition, ensuring continuity in managing the current customer base while expanding its capabilities to serve new global markets.

EarlyHealth’s third acquisition this year underlines its drive to build a global conglomerate at the intersection of healthcare and digital transformation, delivering innovative solutions that expand access for patients, empower industry, and strengthen government capabilities worldwide.

20251010 EHG x CYB3R

About EarlyHealth Group
EarlyHealth Group is a global pharmaceutical services and life sciences company supporting manufacturing, clinical studies, and market access across 60 countries. The Group partners with biopharma, research institutions, and governments to make healthcare accessible through compliant, end-to-end solutions across the value chain.

About CYB3R
CYB3R is a Dubai-headquartered advanced cybersecurity company providing state-of-the-art SOC operations, managed detection and response (MDR), vulnerability testing, and compliance advisory. With a strong focus on applying AI to enhance security maturity, governance, risk and compliance (GRC), and data protection, CYB3R serves a diverse client base that includes government entities, healthcare providers, financial institutions, education networks, and international service providers.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/26f5855c-3e3a-4fa3-875b-be4bf1bc69ad

CONTACT: For media inquiries, please contact EarlyHealth Group Communications: press@early-health.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.